First Horizon Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.16K | Hold |
688
| – | – | ﹤0.01% | 1803 |
|
|
2025
Q1 | $5.16K | Hold |
688
| – | – | ﹤0.01% | 1799 |
|
|
2024
Q4 | $5.17K | Hold |
688
| – | – | ﹤0.01% | 1794 |
|
|
2024
Q3 | $5.23K | Hold |
688
| – | – | ﹤0.01% | 1786 |
|
|
2024
Q2 | $4.25K | Hold |
688
| – | – | ﹤0.01% | 1800 |
|
|
2024
Q1 | $3.5K | Hold |
688
| – | – | ﹤0.01% | 1895 |
|
|
2023
Q4 | $4.12K | Hold |
688
| – | – | ﹤0.01% | 1847 |
|
|
2023
Q3 | $4.87K | Hold |
688
| – | – | ﹤0.01% | 1754 |
|
|
2023
Q2 | $4.84K | Hold |
688
| – | – | ﹤0.01% | 1800 |
|
|
2023
Q1 | $5.74K | Buy |
688
+343
| +99% | +$2.86K | ﹤0.01% | 1762 |
|
|
2022
Q4 | $3.96K | Hold |
345
| – | – | ﹤0.01% | 1855 |
|
|
2022
Q3 | $4K | Buy |
+345
| New | +$4K | ﹤0.01% | 1808 |
|